What reinfections mean for COVID-19

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020

Singanayagam, A., Patel, M., Charlett, A., Lopez Bernal, J., Saliba, V., Ellis, J., Ladhani, S., Zambon, M., & Gopal, R. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.32.2001483 · Cited by 846

Seasonal coronavirus protective immunity is short-lasting

Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767

Genomic evidence for reinfection with SARS-CoV-2: a case study

Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746

Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain

Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1330 · Cited by 271

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

Dearlove, B. L., Lewitus, É., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P. T., Amare, M. F., Vasan, S., Michael, N. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008281117 · Cited by 206

Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain.

Elslande, J. V., Vermeersch, P., Vandervoort, K., Wawina-Bokalanga, T., Vanmechelen, B., Wollants, E., Laenen, L., André, E., Ranst, M. A. V., Lagrou, K., et al. (2020) · Clinical Infectious Diseases · Cited by 133

COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America.Preprint

Prado-Vivar, B., Becerra-Wong, M., Guadalupe, J. J., Márquez, S., Gutiérrez, B., Rojas‐Silva, P., Grunauer, M., Trueba, G. A., Barragán, V., & Cárdenas, P. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3686174 · Cited by 91

Age-specific different immune responses due to capabilities of secreting primal immunoglobulins responding to unexperienced antigensPreprint

Lee, J., Cho, K., Kook, H., Kang, S., Lee, Y., & Lee, J. (2021) · Research Square · doi:10.21203/rs.3.rs-841907/v1

SARS-CoV-2-Impfstoffe und Reaktion des Immunsystems. Kann die epidemische Ausbreitung des Virus durch Impfung verhindert werden?

Schmidt, J., Blessing, F., & Gürtler, L. G. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1550-0001

Containing epidemics in a local cluster via antidote distribution and partial quarantine

Lu, Z., Wahlström, J., & Nehorai, A. (2021) · Physical review. E · doi:10.1103/physreve.104.034307

Hyperimmune immunoglobulin for people with COVID-19

Kimber, C., Valk, S. J., Chai, K. L., Piechotta, V., Iannizzi, C., Monsef, I., Wood, E. M., Lamikanra, A., Roberts, D. J., McQuilten, Z., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015167

Evaluation of the United States COVID-19 Vaccine Allocation StrategyPreprint

Islam, M. R., Oraby, T. F., McCombs, A., Chowdhury, M. M., Al-Mamun, M., Tyshenko, M. G., & Kadelka, C. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3869650

Modeling the Spread of COVID-19 Over Varied Contact Networks

Solorzano, R. L., & Migler, T. (2022) · Studies in computational intelligence · doi:10.1007/978-3-030-93413-2_16

COVID-19 Reinfection and Its Diagnostic Approach

William, A., & Kaur, R. (2021) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/nvst/v2/4321f

Factors Triggering Reinfection of the SARS-CoV-2 Virus in Post-Covid-19 Patients: Systematic Review (Preprint)Preprint

Fu'adah, S. (2021) · doi:10.2196/preprints.32195

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in Congolese individualsPreprint

Ntoumi, F., Batchi-Bouyou, A. L., Djontu, J. C., Vouvoungui, J. C., Mapanguy, C. C. M., Ingoba, L. L., Mougany, J. S., Boumpoutou, R. K., Diafouka-Kietela, S., & Ampa, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1338684/v1

Is it possible to identify SARS-CoV-2 reinfections caused by closely related strains using shotgun sequencing? The analysis of two cases from Ecuador.Preprint

Sevillano, G., Ortega-Paredes, D., Loaiza, K., Zurita-Salinas, C. S., & Zurita, J. (2022) · doi:10.22541/au.164864845.54394765/v1

A Framework for Assessing Social- and Location-Based Transmission Risk as a Heuristic for Individual Decision-MakingPreprint

Eaton, C. D. (2021) · Preprints.org · doi:10.20944/preprints202005.0391.v3

Reinfection, recontamination and revaccination for SARS-CoV-2

Kullmann, T., & Drozgyik, A. (2022) · World Journal of Methodology · doi:10.5662/wjm.v12.i4.258

Diş hekimlerinin koronavirüs pandemisi sürecindeki koronavirüs hastalığı korkusu ve psikolojik durumlarının incelenmesi

Tuğçenur, A. V. C. I., & Arpacıoğlu, S. (2022) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.1038361 · Cited by 2

Ancaman Reinfeksi COVID-19: Tinjauan dari Bukti Pustaka

Adnan, M., & Fauziyati, A. (2022) · Jurnal Penyakit Dalam Indonesia · doi:10.7454/jpdi.v9i3.539 · Cited by 1

SARS-CoV-2 infections in certain groups: A review from COVID-19 study cases

Adzdzakiy, M. M., Asyifa, I. Z., Sativa, A. R., Fiqri, A. R. A., Dharmayanthi, A. B., Prasetyoputri, A., & Saputra, S. (2023) · AIP conference proceedings · doi:10.1063/5.0118551

The Impact of Sputnik SARS-CoV-2 Vaccines on Antibody Response in the Egyptian Population

Ismail, G., Abdelhamid, D. H., Mostafa, M. S., Fahim, N. A. E.-D. M., Elshafei, A., Abdelghaffar, H., Omar, N. N., Taher, O., & Asker, M. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11163

Jump-Drop Adjusted Prediction of Cumulative Infected Cases Using the Modified SIS Model

Mohta, R., Prathapani, S., & Ghosh, P. (2023) · Annals of Data Science · doi:10.1007/s40745-023-00467-3

Fear and Stigma of COVID-19 Reinfection Scale (FSoCOVID-19RS): New Scale Development and Validation

Albikawi, Z. F., Abuadas, M. H., Alalyani, M. M., Zahrani, Y. I., Aqel, E., & Safi, R. (2023) · Healthcare · doi:10.3390/healthcare11101461

Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data

Maniscalco, L., Genovese, D., Ravazzolo, B., Vella, G., Sparacia, B., Vitale, F. M., Matranga, D., & Amodio, E. (2023) · Vaccines · doi:10.3390/vaccines11121757

Psychological Wellbeing of Police as Frontline Warriors During the Peak of the Covid-19 Pandemic in Gujarat: An Observational Survey Study

Bhaskarbhai, T. K. (2023) · International Journal of Nursing and Health Science · doi:10.14445/24547484/ijnhs-v9i3p102

Modeling the Spread of COVID-19 Over Varied Contact Networks

Solorzano, R. L. (2021) · doi:10.15368/theses.2021.106

References

(2024) · Elsevier eBooks · doi:10.1016/b978-0-44-318576-2.00029-9

COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2

Stratton, C. W., & Tang, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00053-8

Trade-offs and political economy during pandemics

Atella, V., & Scandizzo, P. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-44-318576-2.00018-4

Evidence for immunity to SARS-CoV-2 from epidemiological data series

Yubero, P., Lavin, A. A., & Poyatos, J. F. (2024) · F1000Research · doi:10.12688/f1000research.28482.3

Clinically meaningful phenotypes among SARS-CoV-2 reinfections: Informing prevention strategies for future pandemics

Rodriguez-Idiazabal, L., Quintana, J. M., García-Asensio, J., Legarreta, M. J., Larrea, N., & Barrio, I. (2025) · Preventive Medicine · doi:10.1016/j.ypmed.2025.108259

What’s the difference between viral shedding and reinfection with COVID-19?

Herrero, L. J., & Madzokere, E. T. (2020) · doi:10.64628/aa.3e7ujp7ws

Seasonal coronavirus protective immunity is short-lasting

Edridge, A. W. D., Kaczorowska, J., Hoste, A. C. R., Bakker, M., Klein, M., Loens, K., Jebbink, M. F., Matser, A., Kinsella, C. M., Rueda, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1083-1 · Cited by 767

Reinfection With SARS-CoV-2: Implications for Vaccines

Cohen, J. I., & Burbelo, P. D. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1866 · Cited by 111

Natural immune response and protection from SARS-CoV-2 reinfection

Margiotti, K., Fabiani, M., Mesoraca, A., & Giorlandino, C. (2021) · Acta Virologica · doi:10.4149/av_2021_401 · Cited by 2

Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)

Kim, D. S., Rowland‐Jones, S., & Gea‐Mallorquí, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571481 · Cited by 51

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

Hanrath, A. T., Payne, B. A. I., & Duncan, C. J. A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.12.023 · Cited by 103